New research findings of the ENZAMET (ANZUP 1304) study, led by the Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP),...
Vous n'êtes pas connecté
Study finds that transgender women on hormone therapy may have early-stage prostate cancer missed by current PSA screening guidelines.
New research findings of the ENZAMET (ANZUP 1304) study, led by the Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP),...
Studies reported at ESMO 2024 have revealed new groups of women with early-stage (1) and cervical cancers (2) who gain clinically meaningful benefit...
WEDNESDAY, Sept. 18, 2024 -- Black women have a higher risk of dying from any type of breast cancer than white women, a new review finds. Overall, the...
A study reveals a sharp decline in menopausal hormone therapy use among U.S. women, highlighting disparities across racial and ethnic groups over two...
BAYRY moves ahead with the submission of an application seeking approval of darolutamide in combination with androgen deprivation therapy in patients...
SCORES OF men, aged 40 and over, gathered at Independence Park in Savanna-la-Mar, Westmoreland, on September 24 for a special health fair focused on...
The number of suicide attempts among transgender and nonbinary youth in states that passed anti-transgender laws increased by as much as 72% over...
A multi-institutional clinical trial led by Weill Cornell Medicine and New York-Presbyterian investigators showed that a newer technique for...
MONDAY, Sept. 30, 2024 -- From 1999 to 2020, there was a decrease in menopausal hormone therapy (MHT) use among postmenopausal women, according to a...
WEDNESDAY, Sept. 25, 2024 -- Transgender and gender-diverse (TGD) youth have high rates of positive suicide risk screening in the emergency...